TW341574B - METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. - Google Patents

METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.

Info

Publication number
TW341574B
TW341574B TW085115392A TW85115392A TW341574B TW 341574 B TW341574 B TW 341574B TW 085115392 A TW085115392 A TW 085115392A TW 85115392 A TW85115392 A TW 85115392A TW 341574 B TW341574 B TW 341574B
Authority
TW
Taiwan
Prior art keywords
compositions
dioxolane
synthesis
configuration
methods
Prior art date
Application number
TW085115392A
Other languages
English (en)
Chinese (zh)
Inventor
Mansour Tarek
Cimpoia Alex
Bednarski Krzysztof
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Application granted granted Critical
Publication of TW341574B publication Critical patent/TW341574B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW085115392A 1995-12-14 1996-12-13 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. TW341574B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9525606.1A GB9525606D0 (en) 1995-12-14 1995-12-14 Method and compositions for the synthesis of dioxolane nucleosides with › - configuration

Publications (1)

Publication Number Publication Date
TW341574B true TW341574B (en) 1998-10-01

Family

ID=10785435

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085115392A TW341574B (en) 1995-12-14 1996-12-13 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.

Country Status (27)

Country Link
US (4) US5922867A (enExample)
EP (1) EP0970074B1 (enExample)
JP (1) JP3229990B2 (enExample)
KR (1) KR100406159B1 (enExample)
CN (1) CN1080263C (enExample)
AP (1) AP879A (enExample)
AT (1) ATE214699T1 (enExample)
AU (1) AU706328B2 (enExample)
BR (1) BR9612351A (enExample)
CA (1) CA2237730C (enExample)
DE (1) DE69620042T2 (enExample)
DK (1) DK0970074T3 (enExample)
EA (1) EA000844B1 (enExample)
ES (1) ES2172697T3 (enExample)
GB (1) GB9525606D0 (enExample)
HU (1) HU224076B1 (enExample)
IL (3) IL124663A (enExample)
IN (1) IN187349B (enExample)
MX (1) MX9804701A (enExample)
NO (1) NO309901B1 (enExample)
NZ (1) NZ323855A (enExample)
OA (1) OA11094A (enExample)
PL (1) PL188447B1 (enExample)
PT (1) PT970074E (enExample)
TW (1) TW341574B (enExample)
WO (1) WO1997021706A1 (enExample)
ZA (1) ZA9610544B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518899A (ja) 1997-04-07 2001-10-16 トライアングル ファーマシューティカルズ,インコーポレイティド 他の抗ウイルス剤との組合せにおけるmkc−442の使用
EP1535921A1 (en) 1998-08-12 2005-06-01 Gilead Sciences, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
US6979561B1 (en) * 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
EA004767B1 (ru) * 1998-12-23 2004-08-26 Шайре Байокем Инк. Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
JP2002538780A (ja) * 1999-02-11 2002-11-19 シェア バイオケム インコーポレーテッド ヌクレオシド類似体の立体選択的合成
DE60011637T2 (de) * 1999-09-24 2004-11-11 Shire Biochem Inc., Laval Dioxolan nukleosidanalogen zur behandlung und vorbeugung von viralen infektionen
CA2389745C (en) * 1999-11-04 2010-03-23 Shire Biochem Inc. Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
US7038039B2 (en) * 2000-02-10 2006-05-02 Mitsui Chemicals, Inc. Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
AU3144801A (en) * 2000-02-11 2001-08-20 Shire Biochem Inc. Stereoselective synthesis of nucleoside analogues
WO2002051852A1 (fr) * 2000-12-27 2002-07-04 Mitsui Chemicals, Inc. Procede de production d'un derive de saccharide non naturel
CA2867970A1 (en) * 2001-03-01 2002-09-12 Gilead Sciences, Inc. Polymorphic and other crystalline forms of cis-ftc
AU2002329970A1 (en) * 2001-09-04 2003-03-18 Isis Pharmaceuticals, Inc. Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase
EP1441733A1 (en) * 2001-11-02 2004-08-04 Shire Biochem Inc. Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
CN100560073C (zh) * 2001-12-14 2009-11-18 法玛塞特公司 用于治疗病毒感染的n4-酰基胞嘧啶核苷
EP1467990B1 (en) * 2002-01-25 2012-03-07 Shire BioChem Inc. Process for producing dioxolane nucleoside analogue precursors
IL166682A0 (en) 2002-08-06 2006-01-15 Pharmasset Ltd Processes for preparing 1,3-dioxolane nucleosides
AU2003304716A1 (en) 2002-10-15 2005-11-25 Exxonmobil Chemical Patents Inc. Polyolefin adhesive compositions and articles made therefrom
DE10335061B4 (de) 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
KR101157468B1 (ko) * 2004-02-03 2012-07-06 에모리 유니버시티 1,3-디옥솔란 뉴클레오시드 제조방법
US7749531B2 (en) * 2005-06-08 2010-07-06 Indicator Systems International Apparatus and method for detecting bacterial growth beneath a wound dressing
BRPI0813036A2 (pt) * 2007-07-30 2017-10-24 Rfs Pharma Llc processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina.
CN101862676B (zh) * 2009-04-17 2012-01-25 中国石油化工股份有限公司 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
WO2018022263A1 (en) 2016-07-29 2018-02-01 Exxonmobil Chemical Patents Inc. Polymerization processes using high molecular weight polyhydric quenching agents
WO2019245444A1 (en) 2018-06-21 2019-12-26 Medivir Ab Base-modified cytidine nucleotides for leukemia therapy
JP7337539B2 (ja) 2018-06-21 2023-09-04 メディヴィル・アクチエボラーグ 白血病療法のための塩基修飾シチジンヌクレオチド

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
FI932871L (fi) * 1992-06-22 1993-12-23 Lilly Co Eli Stereoselektiv anjonglykosylationsprocess

Also Published As

Publication number Publication date
US20020058670A1 (en) 2002-05-16
US5922867A (en) 1999-07-13
IL124663A0 (en) 1998-12-06
IL144155A (en) 2003-07-06
CN1080263C (zh) 2002-03-06
NO309901B1 (no) 2001-04-17
JP2000501714A (ja) 2000-02-15
HUP9901050A2 (hu) 2001-04-28
AP9801252A0 (en) 1998-06-30
CA2237730A1 (en) 1997-06-19
HU224076B1 (hu) 2005-05-30
ATE214699T1 (de) 2002-04-15
IL124663A (en) 2001-10-31
NZ323855A (en) 1999-11-29
HUP9901050A3 (en) 2001-05-28
MX9804701A (es) 1998-10-31
BR9612351A (pt) 1999-07-13
EA199800555A1 (ru) 1999-02-25
AU1089397A (en) 1997-07-03
EP0970074B1 (en) 2002-03-20
KR100406159B1 (ko) 2004-11-16
US20030060476A1 (en) 2003-03-27
PT970074E (pt) 2002-09-30
AP879A (en) 2000-10-02
WO1997021706A1 (en) 1997-06-19
CN1208414A (zh) 1999-02-17
DK0970074T3 (da) 2002-07-15
OA11094A (en) 2003-03-13
ZA9610544B (en) 1997-07-29
AU706328B2 (en) 1999-06-17
ES2172697T3 (es) 2002-10-01
PL327443A1 (en) 1998-12-07
EP0970074A1 (en) 2000-01-12
CA2237730C (en) 2001-12-04
GB9525606D0 (en) 1996-02-14
DE69620042D1 (de) 2002-04-25
DE69620042T2 (de) 2002-10-17
NO982716L (no) 1998-06-12
KR19990072141A (ko) 1999-09-27
HK1017886A1 (en) 1999-12-03
US6069250A (en) 2000-05-30
IL144155A0 (en) 2002-05-23
IN187349B (enExample) 2002-03-30
EA000844B1 (ru) 2000-06-26
JP3229990B2 (ja) 2001-11-19
PL188447B1 (pl) 2005-02-28
NO982716D0 (no) 1998-06-12

Similar Documents

Publication Publication Date Title
TW341574B (en) METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.
HU912253D0 (en) Process for the production of purinyl-phosphonic acid derivatives
BG100916A (en) Process for the diastereoselective synthesis of nucleoside analogues
TW366350B (en) Processes for the diastereoselective synthesis of nucleosides
BR9302434A (pt) Processo para preparar um nucleosidio enriquecido com beta-anomero
FI104176B1 (fi) Menetelmä nukleosidien uusien antiviraalisten forfolipidijohdannaisten valmistamiseksi
EG20193A (en) Process for preparing of 1,3- oxathiolane nucleoside analogues
ATE140923T1 (de) Verfahren zur herstellung von n4-acyl-5'-desoxy-5-fluorocytidinderivate
SG158136A1 (en) Preparation of 2`-fluoro-2`- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
DE3477791D1 (en) Nucleoside process
ES8707971A1 (es) Un metodo para producir un nucleosido de citosina
FI885094A7 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi
EP0330992A3 (en) Novel cyclobutane derivatives, processes for their preparation and pharmaceutical compositions comprising them
AU2003251936A1 (en) Process for the preparation of 9-beta-anomeric nucleoside analogs
EP0311694A4 (en) Nucleoside derivatives and process for their preparation
NO974512D0 (no) Fremgangsmåte for syntese av nukleosid-analoger
HU9300462D0 (en) New anti-viral compounds and method for producing them
JPS6426594A (en) Nucleotides and antitumor agent
MX9604880A (es) Procedimiento para la sintesis diasteroselectiva de analogos de nucleosido.
GEP20002030B (en) Diastereoselective Synthesis of Nucleosides
JPS5634698A (en) N6-acyl-3'-o(o-nitrobenzyl)adenosine-5'-monophosphate and its preparation
CA2188306A1 (en) Process for the diastereoselective synthesis of nucleoside analogues